Sector valuations Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:00 2026-08-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 3.110 USD | -2.20% |
|
-5.76% | +13.09% |
| Aug. 19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| Aug. 14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -3.11x | 1.5x | 0.11x | 578.49x | -1.51x | -1.53x | -.--% | 355M | |
| 34.28x | 4.56x | 1.32x | 6.11x | 18.18x | 25.57x | 0.94% | 50.47B | |
| -21.19x | 22.09x | -0.33x | 258.61x | -22.63x | -21.15x | -.--% | 44.56B | |
| 33.71x | 6.16x | -35.31x | 3.27x | 14.1x | 21.31x | -.--% | 43.08B | |
| 48.04x | 8.13x | 0.24x | 5.57x | 30.46x | 35.19x | -.--% | 41.7B | |
| 28.96x | 2.36x | 0.6x | 8.75x | 22.11x | 26.25x | 0.4% | 33.21B | |
| 34.16x | 24.51x | 2.26x | 5.6x | 25.43x | 26.61x | -.--% | 16.77B | |
| 24.12x | 2.7x | 0.7x | 2.1x | 9.08x | 14.05x | 1.12% | 14.58B | |
| 77.98x | 4.62x | -0.34x | 4.1x | 15.89x | 19.52x | -.--% | 13.92B | |
| 28.8x | 1.37x | 0.28x | 1.9x | 11.66x | 13.28x | -.--% | 13.12B | |
| -44.89x | 23.49x | -38.36x | 7.57x | 185.26x | -2465.14x | -.--% | 11.56B | |
| 51.99x | 4.57x | 2.6x | 8.69x | 24.42x | 29.4x | 0.44% | 11.35B | |
| 40.35x | 4.64x | 2.6x | 4.74x | 20.5x | 32.24x | 0.56% | 10.96B | |
| -27.46x | 8.08x | 1.03x | 106.91x | -30.43x | -52.96x | -.--% | 10.58B | |
| -28.95x | 9.29x | -2.76x | - | -25.57x | -25.62x | -.--% | 10.18B | |
| -16.77x | 706.76x | -0.32x | 10.99x | -17.63x | -17.01x | -.--% | 10.15B | |
| -30.79x | 8.87x | -7.71x | 80.26x | -20.41x | -19.94x | -.--% | 9.82B | |
| -669.67x | 2.44x | 6.88x | 11x | 65.73x | 86.54x | -.--% | 9.77B | |
| -24.82x | 8.57x | -8.13x | 10350.41x | -20.44x | -20.13x | -.--% | 9.63B | |
| Average | -24.49x | 44.98x | -3.93x | 636.39x | 16.01x | -120.71x | 0.18% | 19.25B | |
| Weighted average by Cap. | 0.72x | 28.30x | -5.15x | 323.19x | 15.26x | -64.62x | 0.24% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
